AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sironi, S.
Right arrow Articles by Del Maschio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sironi, S.
Right arrow Articles by Del Maschio, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 173, 1225-1229, Copyright © 1999 by American Roentgen Ray Society


ARTICLES

Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up

S Sironi, T Livraghi, F Meloni, F De Cobelli, C Ferrero and A Del Maschio
Department of Radiology, Multimedica University Hospital, Milan, Italy.

OBJECTIVE: The purpose of our study was to determine the usefulness of MR imaging in the follow-up evaluation of small hepatocellular carcinoma lesions treated with RF ablation. SUBJECTS AND METHODS: The study group included 37 patients with a single hepatocellular carcinoma lesion less than 3 cm in diameter. A strict protocol required follow-up MR imaging every 6 months after RF treatment. At each follow-up visit, the findings on unenhanced and dynamic gadolinium-enhanced MR images were correlated with those on contrast-enhanced CT images and with results of fine-needle aspiration biopsy. In five patients who underwent surgical resection after the 6-month follow-up examination, comparison with histologic findings of surgical specimens was also performed. RESULTS: Correct diagnosis of complete or partial tumor necrosis was made in 32 (86%) of the 37 patients with the use of unenhanced and dynamic gadolinium-enhanced MR images. Hypointensity on T2-weighted images and loss of enhancement on dynamic MR images corresponded to completely necrotic lesions in all patients. Conversely, intratumoral regions of hyperintensity on T2-weighted images and enhancement on dynamic MR images did not always correlate to residual viable tumor. MR imaging and CT findings agreed in the evaluation of therapeutic response in all patients. CONCLUSION: Our experience confirms that MR imaging is useful for evaluating the effectiveness of RF therapy in achieving tumor regression.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
J. P. McGahan and V. P. Khatri
Imaging Findings after Liver Resection by Using Radiofrequency Parenchymal Coagulation Devices: Initial Experiences
Radiology, June 1, 2008; 247(3): 896 - 902.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M.-h. Park, H. Rhim, Y.-s. Kim, D. Choi, H. K. Lim, and W. J. Lee
Spectrum of CT Findings after Radiofrequency Ablation of Hepatic Tumors
RadioGraphics, March 1, 2008; 28(2): 379 - 390.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. M. Vogt, G. Antoch, P. Veit, L. S. Freudenberg, N. Blechschmid, O. Diersch, A. Bockisch, J. Barkhausen, and H. Kuehl
Morphologic and Functional Changes in Nontumorous Liver Tissue After Radiofrequency Ablation in an In Vivo Model: Comparison of 18F-FDG PET/CT, MRI, Ultrasound, and CT
J. Nucl. Med., November 1, 2007; 48(11): 1836 - 1844.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Dill-Macky, M. Asch, P. Burns, and S. Wilson
Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Am. J. Roentgenol., May 1, 2006; 186(5 Suppl): S287 - S295.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. Morimoto, A. Nozawa, K. Numata, K. Shirato, K. Sugimori, A. Kokawa, N. Tomita, T. Saitou, Y. Nakatani, T. Imada, et al.
Evaluation Using Contrast-Enhanced Harmonic Gray Scale Sonography After Radio Frequency Ablation of Small Hepatocellular Carcinoma: Sonographic-Histopathologic Correlation
J. Ultrasound Med., March 1, 2005; 24(3): 273 - 283.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang
VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor
Radiology, February 1, 2005; 234(2): 423 - 430.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. W. Wilson, R. K. Kerlan Jr, N. A. Fidelman, A. P. Venook, J. M. LaBerge, J. Koda, and R. L. Gordon
Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite--Initial Experience with Four Patients
Radiology, January 1, 2004; 230(1): 287 - 293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. Limanond, P. Zimmerman, S. S. Raman, B. M. Kadell, and D. S. K. Lu
Interpretation of CT and MRI After Radiofrequency Ablation of Hepatic Malignancies
Am. J. Roentgenol., December 1, 2003; 181(6): 1635 - 1640.
[Full Text] [PDF]


Home page
RadioGraphicsHome page
S. K. Kim, H. K. Lim, Y. H. Kim, W. J. Lee, S. J. Lee, S. H. Kim, J. H. Lim, and S. A. Kim
Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings
RadioGraphics, January 1, 2003; 23(1): 107 - 121.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
D. Choi, H. K. Lim, S. H. Kim, W. J. Lee, H.-J. Jang, H. Kim, S. J. Lee, and J. H. Lim
Assessment of Therapeutic Response in Hepatocellular Carcinoma Treated With Percutaneous Radio Frequency Ablation: Comparison of Multiphase Helical Computed Tomography and Power Doppler Ultrasonography With a Microbubble Contrast Agent
J. Ultrasound Med., April 1, 2002; 21(4): 391 - 401.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. Choi, E. M. Loyer, R. A. DuBrow, H. Kaur, C. L. David, S. Huang, S. Curley, and C. Charnsangavej
Radio-frequency Ablation of Liver Tumors: Assessment of Therapeutic Response and Complications
RadioGraphics, October 1, 2001; 21(90001): S41 - 54.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Chopra, G. D. Dodd III, K. N. Chintapalli, J. R. Leyendecker, O. I. Karahan, and H. Rhim
Tumor Recurrence After Radiofrequency Thermal Ablation of Hepatic Tumors: Spectrum of Findings on Dual-Phase Contrast-Enhanced CT
Am. J. Roentgenol., August 1, 2001; 177(2): 381 - 387.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
G. S. Gazelle, S. N. Goldberg, L. Solbiati, and T. Livraghi
Tumor Ablation with Radio-frequency Energy
Radiology, December 1, 2000; 217(3): 633 - 646.
[Abstract] [Full Text]


Home page
RadiologyHome page
H. K. Lim, D. Choi, W. J. Lee, S. H. Kim, S. J. Lee, H.-J. Jang, J.-H. Lee, J. H. Lim, and I. W. Choo
Hepatocellular Carcinoma Treated with Percutaneous Radio-frequency Ablation: Evaluation with Follow-up Multiphase Helical CT
Radiology, November 1, 2001; 221(2): 447 - 454.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Roentgen Ray Society.